Overview
- Weekly weight-loss injections like semaglutide and tirzepatide mimic gut hormones to curb appetite, with UK usage projected to reach one million this year.
- Recent trials show these drugs lower systolic blood pressure by an average of 5 mm Hg, comparable to dedicated hypertension medications.
- Emerging evidence suggests potential benefits for fertility and addiction treatment, including a 40% reduction in alcohol cravings in a small trial.
- Common side effects include nausea, vomiting, diarrhea, and muscle loss, prompting advice to pair treatments with exercise to preserve muscle mass.
- Psychologists caution that appetite suppression without proper support may foster disordered eating, urging integrated psychological screening and education.